

Mycostatin 100,000 Units/mL Topical Cream data sheet May 2019. Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics.

Nilstat 500,000 IU Tablets, 20,000 IU/g Vaginal Cream, 100,000 IU/mL Oral Drops, 500,000 IU Capsules data sheet May 2019. Nystatin Tablet, Coated (Heritage Pharmaceuticals Inc. National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. Nystatin Tablet 500,000 IU (SM Pharmaceuticals Sdn. Nystatin Suspension (McKesson Corporation dba as SKY Packaging).

Nystatin Pessary 100,000 IU Vaginal Tablets (SM Pharmaceuticals Sdn Bhd). Nystatin Oral Suspension BP (Sandoz Limited). Nystatin Ointment (Torrent Pharmaceuticals Limited). Nystatin Cream (Torrent Pharmaceuticals Limited). Nystan 100,000 Units/mL Oral Suspension (Ready-Mixed) (Vygoris Limited). Nystabs Tablets 500,000 Units (Chelonia Healthcare Limited). Nyspes Pessaries 100,000 Units (Chelonia Healthcare Limited). Nystatin Devatis 100,000 IU/mL Oral Drops data sheet August 2021. Candistatin Cream 100,000 Units/g (Idaman Pharma Manufacturing Sdn Bhd). American Society of Health-System Pharmacists, Inc. Wolters Kluwer Clinical Drug Information, Inc. Dosage recommendations may vary among countries and individual products (refer to specific product guidelines).Īnon. For prophylaxis of oral candidiasis in infants born of mothers with vaginal candidiasis: 100,000 units once daily. Continue treatment for at least 48 hours after clinical cure is achieved to prevent relapse. Swish and retain in the mouth, and keep in contact with the affected areas for as long as possible before swallowing. Dosage recommendations may vary among countries and individual products (refer to specific product guidelines).Ĭhild: As susp: Infants 100,000-200,000 units 4 times daily Children and adolescents Same as adult dose. Adult: As susp: 100,000 units 4 times daily, higher doses of 400,000-600,000 units 4 times daily may also be given as necessary swish and retain in the mouth, and keep in contact with the affected areas for as long as possible before swallowing.
